| Cat. No. |
Product Name |
Information |
| PC-35949 |
SR146131
CCK1 inhibitor
|
SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34. |
| PC-70239 |
L-365260
CCK2 inhibitor
|
L-365260 (L365260) is a potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM. |
| PC-70198 |
PF-04756956
CCK1 inhibitor
|
PF-04756956 is a potent, selective CCK1 receptor agonist with EC50 of 0.47 nM. |
| PC-70197 |
CE-326597
CCK1 agonist
|
CE-326597 is a potent, selective agonist of the human and rat CCK1 receptor with Ki of 36 nM. |
| PC-70196 |
JNJ-26070109
CCK2 inhibitor
|
JNJ-26070109 is a novel, potent, selective orally active CCK-2 receptor antagonist with pKi of 8.49 for hCCK2. |
| PC-60082 |
Netazepide
CCK2 inhibitor
|
Netazepide (YF476, Sograzepide) is a potent, selective and orally active gastrin/CCK-2 antagonist with IC50 of 0.1 nM. |
| PC-60036 |
Ceclazepide
CCK2 inhibitor
|
Ceclazepide is a potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD). |
| PC-45389 |
Z-360
CCK2 inhibitor
|
Z-360 (Nastorazepide) is a novel potent, orally active CCK-2/gastrin receptor antagonist with Ki of 0.47 nM. |
| PC-22021 |
Devazepide
CCK1 inhibitor
|
Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of peripheral cholecystokinin (CCK) receptor with IC50 of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors. |
| PC-22020 |
A71623
CCK1 agonist
|
A-71623 (A71623) is a cholecystokinin tetrapeptide (30-33) analogue as potent, highly selective CCK-A (CCK1) cholecystokinin receptor agonist with binding IC50 of 3.7 nM, >1000-fold selective over CCK-B receptor. |
| PC-22019 |
GW-5823
CCK1 agonist
|
GW5823 (GW-5823) a potent, selective orally active, gut-selective CCK1 receptor (CCK-A receptor) agonist with binding pIC50 of 7.64, ED50 of 109 nM in functional assays. |
